¹⁸F-FDG PET/CT in the early prediction of pathological response in aggressive subtypes of breast cancer: review of the literature and recommendations for use in clinical trials.
about
Additional value of 18F-FDG PET/CT response evaluation in axillary nodes during neoadjuvant therapy for triple-negative and HER2-positive breast cancerQuantitative Evaluation of Therapeutic Response by FDG-PET-CT in Metastatic Breast Cancer18FDG-PET/CT for predicting the outcome in ER+/HER2- breast cancer patients: comparison of clinicopathological parameters and PET image-derived indices including tumor texture analysis.Tumor size and proliferative marker geminin rather than Ki67 expression levels significantly associated with maximum uptake of 18F-deoxyglucose levels on positron emission tomography for breast cancers.Prediction of breast cancer recurrence using lymph node metabolic and volumetric parameters from 18F-FDG PET/CT in operable triple-negative breast cancer.Imaging Considerations and Interprofessional Opportunities in the Care of Breast Cancer Patients in the Neoadjuvant Setting.Hybrid 18F-FDG PET/MRI might improve locoregional staging of breast cancer patients prior to neoadjuvant chemotherapy.Is the whole larger than the sum of the parts? Integrated PET/MRI as a tool for response prediction.18FDG-PET/CT and molecular markers to predict response to neoadjuvant chemotherapy and outcome in HER2-negative advanced luminal breast cancers patients.
P2860
Q33730822-476764F0-36BC-47EB-A21D-7D42BB26CEDFQ36883389-6B197350-416E-471C-B711-48E8027BDBF7Q37566580-A05CC174-6DAF-4E2E-A924-4D632C84AFF8Q41491212-8A1E2E9D-90DE-464F-9E52-9F3EEE536420Q47856252-ADC1BA83-2940-432D-A2B1-1AB3C86EB262Q47959144-48EBE47C-72B2-4B1A-AED0-9B4F7CB90C64Q48297177-F724FC07-3236-4DA1-AEB1-1CA4121ECCF8Q48346673-8F19DC8C-F5E2-4DF3-AA3B-64C340416F57Q52584340-661863B9-B90B-4A07-ADA5-38638B81534B
P2860
¹⁸F-FDG PET/CT in the early prediction of pathological response in aggressive subtypes of breast cancer: review of the literature and recommendations for use in clinical trials.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
¹⁸F-FDG PET/CT in the early pr ...... ns for use in clinical trials.
@en
type
label
¹⁸F-FDG PET/CT in the early pr ...... ns for use in clinical trials.
@en
prefLabel
¹⁸F-FDG PET/CT in the early pr ...... ns for use in clinical trials.
@en
P2093
P2860
P1476
¹⁸F-FDG PET/CT in the early pr ...... ns for use in clinical trials.
@en
P2093
David Groheux
David Mankoff
Elif Hindié
Marc Espié
P2860
P2888
P304
P356
10.1007/S00259-015-3295-Z
P50
P577
2016-01-13T00:00:00Z